Effect of Shugan Jianpi Granule (舒肝健脾颗粒) on gut mucosal serotonin-positive cells in patients with irritable bowel syndrome of stagnated Gan-qi attacking Pi syndrome type
Back to article page
OriginalPaper|Updated:2021-08-27
|
Effect of Shugan Jianpi Granule (舒肝健脾颗粒) on gut mucosal serotonin-positive cells in patients with irritable bowel syndrome of stagnated Gan-qi attacking Pi syndrome type
Effect of Shugan Jianpi Granule (舒肝健脾颗粒) on gut mucosal serotonin-positive cells in patients with irritable bowel syndrome of stagnated Gan-qi attacking Pi syndrome type
中国结合医学杂志(英文版)2008年14卷第3期 页码:185-189
Affiliations:
1. Department of Digestive Medicine, the Third Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,China
2. Department of Digestive Medicine, Dongfang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,China
Wang, Zj., Li, Hx., Wang, Jh. et al. Effect of Shugan Jianpi Granule (舒肝健脾颗粒) on gut mucosal serotonin-positive cells in patients with irritable bowel syndrome of stagnated Gan-qi attacking Pi syndrome type., Chin. J. Integr. Med. 14, 185–189 (2008). https://doi.org/10.1007/s11655-008-9001-2
Zai-jian Wang, Hui-xia Li, Jing-hua Wang, et al. Effect of Shugan Jianpi Granule (舒肝健脾颗粒) on gut mucosal serotonin-positive cells in patients with irritable bowel syndrome of stagnated Gan-qi attacking Pi syndrome type[J]. Chinese Journal of Integrative Medicine, 2008,14(3):185-189.
Wang, Zj., Li, Hx., Wang, Jh. et al. Effect of Shugan Jianpi Granule (舒肝健脾颗粒) on gut mucosal serotonin-positive cells in patients with irritable bowel syndrome of stagnated Gan-qi attacking Pi syndrome type., Chin. J. Integr. Med. 14, 185–189 (2008). https://doi.org/10.1007/s11655-008-9001-2DOI:
Zai-jian Wang, Hui-xia Li, Jing-hua Wang, et al. Effect of Shugan Jianpi Granule (舒肝健脾颗粒) on gut mucosal serotonin-positive cells in patients with irritable bowel syndrome of stagnated Gan-qi attacking Pi syndrome type[J]. Chinese Journal of Integrative Medicine, 2008,14(3):185-189. DOI: 10.1007/s11655-008-9001-2.
Effect of Shugan Jianpi Granule (舒肝健脾颗粒) on gut mucosal serotonin-positive cells in patients with irritable bowel syndrome of stagnated Gan-qi attacking Pi syndrome type
摘要
To evaluate the effect of Shugan Jianpi Granule (舒肝健脾颗粒
SJG) on the number of gut mucosal serotonin-positive cells (5-HT+C) in patients with irritable bowel syndrome (IBS) of stagnated Gan-qi attacking Pi (SGAP) syndrome type. Twenty-four patients were randomized equally into three groups. All were treated with the basic conventional treatment by cognition-behavior therapy with assistance of lactein 3 tablets thrice a day. Additionally
24 g of SJG was given three times a day to group A
and the same dosage of SJG and Smecta 15 g thrice a day was given to group B
while no additional treatment was given to the control group. The number of 5-HT+C was measured respectively before and two weeks after treatment by immunohistochemical method. The number of 5-HT+C decreased after treatment in all the three groups (P<0.05)
but the decrement was more significant in the two test groups than in the control group (P<0.05 and P<0.01
respectively)
while comparison of 5-HT+C between the two test groups showed insignificant difference (P>0.05). SJG can reduce the number of 5-HT+C in IBS patients of SGAP syndrome type
and its effect is enhanced when used in combination with Smecta.
Abstract
To evaluate the effect of Shugan Jianpi Granule (舒肝健脾颗粒
SJG) on the number of gut mucosal serotonin-positive cells (5-HT+C) in patients with irritable bowel syndrome (IBS) of stagnated Gan-qi attacking Pi (SGAP) syndrome type. Twenty-four patients were randomized equally into three groups. All were treated with the basic conventional treatment by cognition-behavior therapy with assistance of lactein 3 tablets thrice a day. Additionally
24 g of SJG was given three times a day to group A
and the same dosage of SJG and Smecta 15 g thrice a day was given to group B
while no additional treatment was given to the control group. The number of 5-HT+C was measured respectively before and two weeks after treatment by immunohistochemical method. The number of 5-HT+C decreased after treatment in all the three groups (P<0.05)
but the decrement was more significant in the two test groups than in the control group (P<0.05 and P<0.01
respectively)
while comparison of 5-HT+C between the two test groups showed insignificant difference (P>0.05). SJG can reduce the number of 5-HT+C in IBS patients of SGAP syndrome type
and its effect is enhanced when used in combination with Smecta.
Costedio MM, Hyman N, Mawe GM. Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum 2007; 50:376–388.
Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–1390.
Chen ZS, Zhang WD, Wei BH, et al. Schedule for diagnosis and treatment for irritable bowel syndrome with integrative Chinese and Western medicine (Draft). Chin J Integr Tradit West Med (Chin) 2005;25(3):282–284.
Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007;132:397–414.
Wang ZJ, Ouyang Q, Zou YG, et al. Comparison of mucosal serotonin content in patients with ulcerative colitis and irritable bowel syndrome. Chin J Intl Med (Chin) 2005;44(11):851–852.
Wang ZJ, Ouyang Q, Wei B, et al. Alteration of intestinal mast cells in cases with overlap syndrome inside ulcerative colitis and irritable bowel syndrome. J Clin Intl Med (Chin) 2005;22(10):674–677.
Han MH, Chen TQ. Exploration on evolvement rule and syndrome differentiation of diarrea-predominant irritable bowel syndrome. Guangming J Tradit Chin Med (Chin) 2007;22(3):35–36.
Qin ZS, Wang Y, Zhao Y, et al. Effect of Shugan Jianpi Granule on VIP and IL-10 in rats with ulcerative colitis. Jilin J Tradit Chin Med (Chin) 2007;27(3):48–50.
Tao Y, Chen DM, Dong MX, et al. The clinical study on Shugan Decoction in treating diarrhea-predominant irritable bowel syndrome. Chin Arch Tradit Chin Med (Chin) 2007;25(10):2190–2193.
Atkinson W, Lockhart S, Whorwell PJ, et al. Altered 5-hydroxytryptamine signaling in patients with constipation and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006;130:34–43.
Irritable bowel syndrome: Common integrative medicine perspectives
Thinking and strategy on the diagnosis and treatment of functional gastrointestinal disorders with integrative medicine
Traditional Chinese medicine clinical experience of the treatment for irritable bowel syndrome
Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine
Effect of modified Sinisan on anorectal manometry of the constipation predominant type of irritable bowel syndrome
相关作者
暂无数据
相关机构
Seekers Centre for Integrative Medicine
Digestive Disease Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Department of Gastroenterology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Institute of Digestive Disease, Shanghai University of Traditional Chinese Medicine
Department of Integrated Chinese and Western Medicine, West China Hospital, Sichuan University
Anorectal Department, Nanjing Municipal TCM Hospital